G. Rossi

Hema e-Chart: Italian Registry for Prospective Analysis of Epidemiology, Management and Outcome of Febrile Events in Patients with Hematological Malignancies

L. Pagano, F. Locatelli, F. Aversa, 2010, Journal of chemotherapy.

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

K. Savage, F. Morschhauser, L. Trümper, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Nocardia spp infections among hematological patients: results of a retrospective multicenter study.

L. Pagano, M. Caira, G. Rossi, 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria

L. Pagano, F. Aversa, G. Nadali, 2018, Annals of Hematology.

[Splenectomy in immune thrombocytopenia and other hematological diseases].

G. Rossi, T. Piardi, G. Ottaviani, 1999, Il Giornale di chirurgia.

A prospective survey of febrile events in hematological malignancies

L. Pagano, F. Aversa, M. Morselli, 2012, Annals of Hematology.

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir

L. Cavanna, M. Luppi, P. Barozzi, 2005, Leukemia.

Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab

K. Dobbs, J. Chiorini, H. Su, 2021, Blood Cancer Journal.